-
Blood test predicts treatment response for metastatic prostate cancer
europeanpharmaceuticalreview
July 03, 2018
Testing could lead to extension of life through improved clinical decision-making by identifying patients who need to switch from targeted hormonal therapy to chemotherapy…
-
Elderly cancer cases to increase 80% by 2035, says CRUK
pharmafile
June 22, 2018
A new report from Cancer Research UK has indicated that the number of UK? citizens over the age of 75 with cancer is predicted to rise by up to 80% by the year 2035.
-
Antiviral Treatments Reduce Cancer Risk for HIV Patients
drugs
June 12, 2018
People with HIV are at increased risk for both?AIDS-related cancers (Kaposi sarcoma, non-Hodgkin lymphoma or invasive cervical cancer) and non-AIDS-related cancers (lung and larynx cancer, melanoma and leukemia).
-
Lengthy Viral Suppression May Cut Cancer Risk in HIV Infected
drugs
June 12, 2018
Antiretroviral therapy resulting in long-term viral suppression of HIV may contribute to cancer prevention, according to a study published online June 12 in the?Annals of Internal Medicine.
-
Sri Lanka to register two foreign cancer vaccines
biospectrumasia
June 08, 2018
The Russian vaccine ‘Hearticad’ which was brought down by the minister was rejected by the Sri Lanka College of Oncologists.
-
DNA test may detect liver cancer
europeanpharmaceuticalreview
June 08, 2018
A group of researchers have completed a phase II study comparing a set of DNA markers to alpha-fetoprotein as a method to test for liver cancer….
-
Janssen debuts promising new cancer data at ASCO
pharmafile
June 07, 2018
Janssen took the opportunity at the American Society of Clinical Oncology (ASCO) annual event to present promising new Phase 2 and 3 data on two of its candidates
-
Trial to test cancer combo in both adults and children
pharmatimes
June 06, 2018
UK researchers have launched an early stage trial designed to help assess whether AstraZeneca and MSD’s selumetinib could be effective in combination with dexamethasone as a treatment for leukaemia.
-
Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
worldpharmanews
June 05, 2018
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.
-
Tiny particles could help fight brain cancer
worldpharmanews
June 05, 2018
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
